Trading Signals: HALO Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Halozyme Therapeutics Inc)
| HALO latest price $33.8000 (3.08%) ($33.8000 - $33.8000) on Wed. Feb. 23, 2022. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.83% (three month average) | RSI | 42 | Latest Price | $33.8000(3.08%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | HALO declines -0.4% a day on average for past five trading days. | Weekly Trend | HALO declines -1.6% a week on average for past two weeks. | Market Behavior | Broad based sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support HALO advance at 0% a week (0% probability) IBB(51%) IWO(46%) IWM(45%) IWN(42%) IWC(41%) | Factors Impacting HALO price | HALO will decline at least -1.415% in a week (0% probabilities). VIXM(-25%) UUP(-11%) VXX(-8%) GLD(-4%) TBT(-3%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.415% (StdDev 2.83%) | Hourly BBV | 1.2 () | Intraday Trend | 0% | | | |
|
Resistance Level | $33.89 | 5 Day Moving Average | $33.35(1.35%) | 10 Day Moving Average | $33.9(-0.29%) | 20 Day Moving Average | $33.89(-0.27%) | To recent high | -17.6% | To recent low | 6.3% | Market Cap | $4.62b | | | | Halozyme Therapeutics, Inc. is a biopharmaceutical company, which engages in research, development & commercialization of human enzymes and drug candidates. It focuses on novel oncology therapies that target the tumor microenvironment. Its products include PEGPH20, HTI-1511, PEG-ADA2, and HYLENEX recombinant. The company was founded by Gregory Ian Frost on February 26, 1998 and is headquartered in San Diego, CA. |